Opinion: The Myth About Masks

Outdated studies, misunderstood guidance, and the persistence of a safety claim the author says does not hold up.

Pilot in flight deck
Pilot executing pre-flight procedures in a commercial airliner cockpit before takeoff. (Photo: Shutterstock | l i g h t p o e t)
Gemini Sparkle

Key Takeaways:

  • The article refutes the belief that beards compromise pilot oxygen mask safety, calling it an unsubstantiated myth despite its use by airlines like Alaska Airlines to justify beard bans.
  • Traditional justifications for beard bans, including a 47-year-old FAA advisory and misapplied OSHA studies, are based on outdated or irrelevant research that does not accurately reflect modern aviation mask performance.
  • Recent, rigorous studies conducted under realistic aviation conditions (hypoxia and smoke) have consistently shown that facial hair does not compromise the effectiveness of modern pilot oxygen masks.
  • The persistence of this "mask myth" allows airlines to enforce grooming preferences under the guise of safety, rather than being supported by demonstrable risk or credible, current data.
See a mistake? Contact us.

A recent article examined Alaska Airlines’ decision to prohibit beards among its pilots, presenting the policy as a safety measure tied to concerns about oxygen mask leakage during decompression events. The airline cited a long-standing belief that facial hair can compromise mask seals and impair a pilot’s ability to respond effectively in an emergency. The article also referenced my 2025 study, which challenges that assumption.

This piece aims to clarify why the belief that beards significantly degrade aviation mask performance is a myth—not merely debatable, but unsupported by credible, relevant data. More importantly, it explores why this belief persists: it provides a convenient way for airlines to frame grooming preferences as safety requirements.

The Myth of Regulatory “Reaffirmation”

The article quoted Alaska Airlines’ Vice President of Flight Operations, David Mets, who suggested that the FAA has recently “reaffirmed” its position on beards and pilot safety. However, no such reaffirmation exists in FAA policy or public statements.

This claim appears to lend renewed authority to a 47-year-old document: FAA Advisory Circular AC 120-43. Many airlines rely on this circular to justify beard bans, citing its conclusion that facial hair could impair mask performance during emergencies.

Yet the foundation of this advisory is what might be called “legacy science”—primarily studies conducted by OSHA on industrial respirators. These studies demonstrate that beards can compromise seals in equipment designed for prolonged use in highly toxic environments, where even microscopic particle leakage can be fatal.

This is not comparable to aviation. Pilot oxygen masks are designed for short-term emergency use—typically around ten minutes—providing sufficient oxygen for descent to a safe altitude. OSHA has never tested aviation masks under aviation conditions, and its standards were never intended to evaluate their effectiveness. Applying those findings to cockpit oxygen systems is a category error.

The Myth of Longstanding FAA Evidence

The FAA’s advisory circular references a single aviation-related study: a non-peer-reviewed presentation from 1979 delivered at a conference in Las Vegas. This study tested just four participants and concluded that “a decrement in mask efficiency did occur because of the presence of beards.”

The limitations are significant:

  • The sample size (n=4) is far too small to support general conclusions
  • No statistical analysis was performed
  • Key methodological details—such as mask types and measurement units—were not clearly reported

In reviewing the data, I conducted a statistical power analysis on one of the mask conditions. The results indicate that approximately 29 participants would have been required to achieve statistical significance. Instead, conclusions were drawn by visually interpreting a small dataset—effectively “eyeballing” the results.

Even more importantly, the study measured oxygen content in exhaled air at ground level. It did not simulate hypoxia or decompression conditions. Yet its findings have been extrapolated for decades to suggest that bearded pilots would be at risk of hypoxia at altitude—an inference unsupported by the data. Hypoxia causes many physiological compensatory mechanisms such as more frequent, shallower breathing, increased heart rate, vasoconstriction in the lungs and vasodilation in the systemic circulation. 

Despite these flaws, this single, limited study — combined with misapplied OSHA research — has shaped policy and practice across the airline industry for nearly half a century.

If the FAA truly believed that beards posed a significant safety risk, it would be obligated to prohibit them outright. It has not done so.

What the Evidence Actually Shows

To date, only two studies have directly examined aviation oxygen mask performance under realistic conditions:

  • A study conducted at Simon Fraser University using a hypobaric chamber
  • A study conducted at Embry-Riddle Aeronautical University using a normobaric hypoxia chamber

Both studies tested modern aviation masks (circa 2020) under hypoxic and smoke/fume conditions. Both found that mask effectiveness was not compromised by facial hair of any length.

In contrast to the 1979 FAA study, these experiments used sufficient sample sizes and appropriate statistical methods. For example, a power analysis of the ERAU data indicated that only 12 participants were needed to detect meaningful effects due to low variability; the study included twice that number.

Inside a Boeing 787 Dreamliner flight deck at the Farnborough Airshow
Inside a Boeing 787 Dreamliner flight deck at the Farnborough Airshow. (Photo: AirlineGeeks | William Derrickson)

Participants were also exposed to highly volatile substances designed to test mask leakage. While wearing masks, none could detect these substances. Without masks, their reactions were immediate and pronounced. This suggests that even small, highly mobile molecules could not penetrate the seal — making it unlikely that larger smoke or fume particles would do so.

These findings represent the only direct, modern evidence on aviation mask performance with bearded users. They cannot be dismissed simply because they conflict with longstanding assumptions.

The “Abundance of Caution” Argument

Some argue that banning beards is justified as a precaution—even in the absence of strong evidence. But this position deserves scrutiny.

Policies framed as safety measures should be grounded in demonstrable risk. When they are not, they risk becoming tools for enforcing preferences under the guise of safety. Airlines are within their rights to set grooming standards—but those standards should be presented transparently, not justified by unsupported claims.

There is also a broader consideration. Facial hair can be tied to religious practice, medical conditions, or cultural expression. Restrictions, therefore, extend beyond aesthetics into questions of personal and social freedom.

As William James observed, “a difference that makes no difference is no difference at all.” If facial hair does not materially affect safety, then its prohibition should not be defended on that basis.

The belief that beards compromise aviation oxygen masks to the point of impairing pilot performance is not supported by credible evidence. It persists not because it has been proven, but because it has gone insufficiently challenged.

Rather than relying on outdated studies and misapplied research, the industry would benefit from continued, rigorous investigation. If safety is truly the priority, then conclusions must be driven by data—not tradition, assumption, or convenience.

Until such evidence exists, the “mask myth” remains just that: a myth.

Jon French, PhD

Jonathan French retired from 23 years of teaching Aerospace Physiology and neurosciences at Embry-Riddle Aeronautical University in May 2025. Prior to ERAU, Dr French was an Aerospace Physiologist for the USAF. Before that, he worked for a major pharmaceutical company as part of a team that developed the first FDA approved Alzheimer’s drug. Currently, he continues to research and write papers about the effects of hypoxia on the vestibular system and Aerospace neuropharmacology, among other topics.
Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE

Uh-oh! It looks like you're using an ad blocker.

Our website relies on ads to provide free content and sustain our operations. By turning off your ad blocker, you help support us and ensure we can continue offering valuable content without any cost to you.

We truly appreciate your understanding and support. Thank you for considering disabling your ad blocker for this website